Vandhana V, Saralaya K Vishwas, Bhat Sevitha, Shenoy Mulki Shalini, Bhat Archana K
Department of Microbiology, Kasturba Medical College, Manipal Academy of Higher Education, Mangalore 575001, Manipal, Karnataka, India.
Int J Microbiol. 2022 Aug 18;2022:4532707. doi: 10.1155/2022/4532707. eCollection 2022.
Hypervirulent (Hv-Kp) is an emerging variant of classical (C-Kp) that exhibits hypermucoviscocity and possesses multiple siderophores as virulence factors and is known to cause serious debilitating infections in immunocompetent individuals. The aim of this study is to identify C-Kp and Hv-Kp strains and detect their virulence factors and antimicrobial susceptibility patterns.
A total of 129 isolates from different clinical samples were used for the identification and differentiation of classical (C-Kp) and hypervirulent (Hv-Kp) to correlate their virulence with antimicrobial susceptibility patterns and identify their risk factors. Hypermucoviscosity was determined by a string test (>5 mm of string length). The aerobactin gene was detected by PCR. In total, 13.9% (18/129) were Hv-Kp and 86.1% (111/129) were C-Kp. Only 50% (9/18) of the Hv-Kp isolates were hypermucoviscous. C-Kp was significantly more resistant to antimicrobials than Hv-Kp. Among C-Kp, 75.7% were ESBL producers and 76.6% were multidrug resistant while in Hv-Kp, 44.44% were both ESBL producers and multidrug-resistant which is statistically significant ( < 0.01). Diabetes was a common risk factor for C-Kp infections whereas, respiratory disorders like COPD and prolonged ICU stay were the risk factors for Hv-Kp infections. The mortality rate among patients with Hv-Kp infections (87.5%) was significantly high when compared to that of C-Kp infections (35.7%) ( < 0.001). A majority of hypermucoviscous isolates were multidrug resistant (65.2%). Although the prevalence of Hv-Kp infections was low, a high percentage of them were multidrug resistant with a significantly high mortality rate. Hence, it is important to efficiently identify Hv-Kp strains from clinical samples and determine their antimicrobial susceptibility patterns, so as to provide immediate and effective treatment and to prevent possible outbreaks.
高毒力肺炎克雷伯菌(Hv-Kp)是经典肺炎克雷伯菌(C-Kp)的一种新兴变体,表现出高黏液黏稠度,拥有多种铁载体作为毒力因子,并且已知会在免疫功能正常的个体中引起严重的衰弱性感染。本研究的目的是鉴定C-Kp和Hv-Kp菌株,检测它们的毒力因子和抗菌药物敏感性模式。
总共129株来自不同临床样本的分离株用于经典肺炎克雷伯菌(C-Kp)和高毒力肺炎克雷伯菌(Hv-Kp)的鉴定与区分,以将它们的毒力与抗菌药物敏感性模式相关联,并确定其危险因素。通过拉丝试验(拉丝长度>5毫米)确定高黏液黏稠度。通过聚合酶链反应检测气杆菌素基因。总共,13.9%(18/129)为Hv-Kp,86.1%(111/129)为C-Kp。仅50%(9/18)的Hv-Kp分离株具有高黏液黏稠度。C-Kp对抗菌药物的耐药性明显高于Hv-Kp。在C-Kp中,75.7%为超广谱β-内酰胺酶(ESBL)产生菌,76.6%为多重耐药菌,而在Hv-Kp中,44.44%既是ESBL产生菌又是多重耐药菌,这具有统计学意义(<0.01)。糖尿病是C-Kp感染的常见危险因素,而慢性阻塞性肺疾病(COPD)等呼吸系统疾病和重症监护病房(ICU)长期住院是Hv-Kp感染的危险因素。与C-Kp感染患者的死亡率(35.7%)相比,Hv-Kp感染患者的死亡率(87.5%)显著更高(<0.001)。大多数具有高黏液黏稠度的分离株为多重耐药菌(65.2%)。尽管Hv-Kp感染的患病率较低,但其中很大一部分具有多重耐药性,死亡率显著较高。因此,从临床样本中有效鉴定Hv-Kp菌株并确定其抗菌药物敏感性模式非常重要,以便提供及时有效的治疗并预防可能的暴发。